Generics 130

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Betamethasone dipropionate manufacturers

130 products found

Filters

130 products found

betamethasone dipropionate + salicylic acid

Cutaneous solution 0.5 mg + 20 mg - 100 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Portugal
Manufacturer #461
A pharmaceutical manufacturer based in the EU that is active in 10+ countries selling its products in Europe, Africa, Asia, and LATAM. The company's key therapeutic areas are ophthalmology, dermatology, otorhinolaryngology, and dermo-cosmetics. Key production lines are medicine, medical devices, cosmetics, body care products, and food supplements with GMP. The company does eCTD dossier preparation.

Manufacturer usually replies in 9 days

betamethasone dipropionate + salicylic acid

Cutaneous ointment 0.5 mg/g + 30 mg/g - 30 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Registered in
Portugal
Manufacturer #461
A pharmaceutical manufacturer based in the EU that is active in 10+ countries selling its products in Europe, Africa, Asia, and LATAM. The company's key therapeutic areas are ophthalmology, dermatology, otorhinolaryngology, and dermo-cosmetics. Key production lines are medicine, medical devices, cosmetics, body care products, and food supplements with GMP. The company does eCTD dossier preparation.

Manufacturer usually replies in 9 days

betamethasone dipropionate + salicylic acid

Cutaneous ointment (0.5mg+30mg)/g - 30g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #392
A pharmaceutical manufacturer based in the EU that has been active in 10+ countries selling its products in Europe, and CIS for 50+ years. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are GMP-compliant. Main dosage forms include solid, liquid, and semi-liquid forms.

Manufacturer usually replies in 8 days

betamethasone dipropionate

Pressurised inhalation, solution 50 mcg, 100 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17633
In the 1950s, the pharmaceutical laboratory was established. Its first manufacturing facility for inhalation aerosols was established in the 1960s, making it one of the first companies to introduce such a product to the market. It was one of the first firms in the world to sell silver sulfadiazine as a pharmaceutical product in cream and aerosol form.

Manufacturer usually replies in 9 days

betamethasone dipropionate + gentamicin sulfate + clotrimazole

Cream 0.63 mg/g + 1.54 mg/g + 10 mg/g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15086
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines are Rx, OTC, medical devices, nutraceuticals, and cosmetics. The company's production lines are GMP-compliant. ain therapeutic areas include respiratory, dermatology, and urinary. The main dosage forms include solid oral, liquid, and semi-solid.

Manufacturer usually replies in 19 days

betamethasone dipropionate + salicylic acid

Cutaneous ointment 0.5 mg/g + 30 mg/g - 15 g

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Serbia , Vietnam
Comments
Dossier with limited production and/or regulatory support
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

betamethasone dipropionate

Cream 0.5 mg/g - 15 g

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Serbia , Vietnam
Comments
Dossier with limited production and/or regulatory support
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

betamethasone dipropionate + neomycin + clotrimazole

Cream 0.05 % + 0.05 % + 1 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13225
It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 3 days

betamethasone dipropionate + gentamicin + clotrimazole

Cream 0.05 % + 0.1 % + 1 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13225
It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 3 days

betamethasone dipropionate

Cream 0.05 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13225
It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 3 days

betamethasone dipropionate + gentamicin

Cream 0.64 mg + 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #13225
It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 3 days

betamethasone dipropionate + salicylic acid + zinc oxide

Cutaneous ointment 0.05 % + 6.5 % + 0.5 % - 20 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

betamethasone dipropionate + salicylic acid

Cutaneous lotion 0.05 % + 2 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

betamethasone dipropionate + salicylic acid

Cutaneous ointment 0.05 % + 3 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
FDA
Manufacturer #20861

Manufacturer usually replies in 4 days

betamethasone dipropionate + betamethasone sodium phosphate

Injection, pre-filled syringe 5 mg + 2 mg/ml - 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Comments
RX
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

betamethasone dipropionate + betamethasone sodium phosphate

Suspension for injection/infusion 5 mg + 2 mg/ml - 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Unavailable markets
Iraq , Kazakhstan , Ukraine , Uzbekistan , Vietnam
Comments
RX
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

betamethasone dipropionate + clotrimazole

Cream 6.4 mg + 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #21647

Manufacturer usually replies in 2 days

betamethasone dipropionate + gentamicin + zinc sulphate

Cutaneous ointment 0.05 % + 0.1 % + 2.5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

betamethasone dipropionate + miconazole + neomycin sulfate

Cutaneous ointment 0.025 % + 2 % + 0.50 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

betamethasone dipropionate + clotrimazole

Cream 0.5 % + 1 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
WHO
Manufacturer #20624

Manufacturer usually replies in 2 days

Want to view all 130 products? Create your free account today!

Betamethasone dipropionate

Betamethasone dipropionate is classified as a super high potency corticosteroid used as an anti-inflammatory or immunosuppressive agent. Betamethasone dipropionate treats a wide range of skin conditions like eczema, dermatitis, allergies, and rashes. It’s actions reduce the swelling, itching, and redness caused by these conditions. Betamethasone dipropionate is prescribed in the treatment of cutaneous T-cell lymphoma, seborrheic dermatitis that causes allergic red and itchy skin called atopic dermatitis. Also prescribed to cure contact dermatitis, inflammation of the skin due to an allergy and contact with the offensive substance, granuloma Annulare, plaque psoriasis, psoriasis of itching of the anus, itching of the genital area, scalp, skin rash that becomes thick and discolored from rubbing it, skin inflammation and itching. It is commonly used in combination with other drugs such as Luxiq, Lotrisone, and Taclonex. Betamethasone dipropionate is sold under the brand names Alphatrex, Beta-Val, and Diprolene amongst others. Merck patented Betamethasone dipropionate in 1987 was, as an augmented cream/lotion, in the U.S. and Europe. But these patents have expired since then leading to a generic production of betamethasone dipropionate by several other local manufacturers in countries around the world.

Dosage, forms, and application:

Betamethasone dipropionate is available systemically (injectable and oral) and as Topical formulations with medium to very high potency. Its cream/lotion/ointment are available in 0.05%, 0.1%, concentrations whereas the gel has only the 0.05% variant. It’s foam form has a strength of 0.12% and the spray has 0.05% of medicine per gram. In the treatment of Plaque Psoriasis, indicated for treating mild-to-moderate plaque psoriasis in adults, the patient has to apply it directly to the affected area once every 12 hours. In the treatment of Steroid-Responsive Dermatoses, the patient has to apply the ointment, cream, lotion, or gel once every 12 hours.

The price of Betamethasone dipropionate

In the USA, consumers have to pay an average retail price of $82.43 for a generic tube of cream of 45g of 0.05% concentration of this medicine. The price of this medicine is significantly cheaper in India with prices as low as USD5 for the same supply.

How does Betamethasone dipropionate work?

Betamethasone is corticosteroids. Broadly speaking, its actions activate natural substances in the skin to reduce swelling, redness, and itching. It achieves this by binding to specific intracellular glucocorticoid receptors. It then subsequently binds to DNA modifying the gene expression. The resulting synthesis induces anti-inflammatory proteins while prohibiting the synthesis of other inflammatory mediators..

Finding Betamethasone dipropionate Manufacturers and Suppliers

The best way to find and gain access to Betamethasone dipropionate manufacturers and Betamethasone dipropionate suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Betamethasone dipropionate can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Betamethasone dipropionate to work with. You can fine-tune your search results using various filters too, letting you search for Betamethasone dipropionate from specific countries.